Lars Valeur Køber

Lars Valeur Køber

Clinical Professor

Member of:

  • Internal medicine: Cardiology


  1. 2019
  2. Published

    Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial

    Kristensen, S. L., Levy, W. C., Shadman, R., Nielsen, J. C., Haarbo, J., Videbæk, L., Bruun, Niels Eske, Eiskjær, H., Wiggers, H., Brandes, A., Thøgersen, A. M., Hassager, Christian, Svendsen, Jesper Hastrup, Høfsten, Dan Eik, Torp-Pedersen, C., Pehrson, S., Signorovitch, J., Køber, Lars Valeur & Thune, J. J., 2019, In: J A C C: Heart Failure. 7, 8, p. 717-724 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Risk of readmission and death in patients admitted with new-onset versus worsening heart failure: insights from a nationwide cohort

    Butt, Rizwan Ahmed, Fosbol, E. L., Andersson, C., Gerds, Thomas Alexander, Mcmurray, J. J. V., Petrie, M. C., Gustafsson, Finn, Madelaire, C., Kristensen, S. L., Gislason, Gunnar Hilmar, Torp-Pedersen, C., Køber, Lars Valeur & Schou, Morten, 2019, In: European Journal of Heart Failure. 21, S1, p. 496 1 p., 1932.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Published

    SGLT-2 inhibitors versus GLP-1 receptor agonists and risk of mortality, chronic kidney disease and hospitalisation for heart failure in patients with type 2 diabetes

    Noergaard, C., Torp-Pedersen, C., Vestergaard, P., Wong, N., Gerds, Thomas Alexander, Starkopf, L., Bonde, A., Fosbol, E., Køber, Lars Valeur & Lee, C., 2019, In: European Heart Journal. 40, Supplement 1, p. 56 1 p., 194.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Published

    Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

    Düngen, H., Køber, Lars Valeur, Nodari, S., Schou, Morten, Otto, C., Becka, M., Kanefendt, F., Winkelmann, B. R., Gislason, Gunnar Hilmar, Richard, F., Nielsen, Olav Wendelboe, Gheorghiade, M. & Senni, M., 2019, In: Clinical Pharmacology in Drug Development. 8, 7, p. 942-951 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments

    Alstrup, M., Meyer, J., Schultz, M., Rasmussen, L. J. H., Rasmussen, L. S., Køber, Lars Valeur, Forberg, J. L., Eugen-Olsen, J. & Iversen, Kasper, 2019, In: World Journal of Surgery. 43, 3, p. 780-790

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure

    Rørth, R., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Signorovitch, J., Bruun, Niels Eske, Eiskjær, H., Hassager, Christian, Svendsen, Jesper Hastrup, Høfsten, Dan Eik, Torp-Pedersen, C., Pehrson, S., Køber, Lars Valeur & Kristensen, S. L., 2019, In: Europace. 21, 8, p. 1203-1210 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial

    Bundgaard, J. S., Thune, J. J., Nielsen, J. C., Videbæk, R., Haarbo, J., Bruun, N. E., Videbæk, L., Aagaard, D., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Eiskjær, H., Brandes, A., Thøgersen, A. M., Melchior, T. M., Pedersen, O. D., Gustafsson, F., Egstrup, K., Hassager, C. & 7 others, Svendsen, Jesper Hastrup, Høfsten, Dan Eik, Torp-Pedersen, C., Pedersen, S. S., Pehrson, S., Køber, Lars Valeur & Mogensen, U. M., 2019, In: Europace. 21, 6, p. 900-908

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation

    Vinding, N. E., Bonde, A. N., Rørth, R., Lamberts, Morten Kjøbek, Olesen, J. B., Gislason, Gunnar Hilmar, Torp-Pedersen, C., Køber, Lars Valeur & Fosbøl, E. L., 2019, In: Europace. 21, 4, p. 572-580

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The relationship between volumetric thoracic bone mineral density and coronary calcification in men and women: results from the Copenhagen General Population Study

    Wiegandt, Y. L., Sigvardsen, P. E., Sørgaard, M. H., Knudsen, A. D., Rerup, S. A., Kühl, J. T., Fuchs, A., Køber, Lars Valeur, Nordestgaard, Børge & Kofoed, Klaus Fuglsang, 2019, In: Bone. 121, p. 116-120

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI

    Laursen, P. N., Holmvang, Lene, Lønborg, J., Køber, Lars Valeur, Høfsten, Dan Eik, Helqvist, S., Clemmensen, P., Kelbæk, H., Jørgensen, E., Lassen, J. F., Pedersen, F., Høi-Hansen, T., Raungaard, B., Terkelsen, C. J., Jensen, L. O., Sadjadieh, G. & Engstrøm, Thomas, 2019, In: International Journal of Cardiology. 289, p. 1-5

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 543423